Literature DB >> 35496448

Reply to the Editor - Are we close to a major impact on prevention of sudden cardiac death among coronary artery disease patients?

Michael C Downey1,2, Matthew Hooks1,2, Selçuk Adabag1,2.   

Abstract

Entities:  

Year:  2022        PMID: 35496448      PMCID: PMC9043355          DOI: 10.1016/j.hroo.2022.02.009

Source DB:  PubMed          Journal:  Heart Rhythm O2        ISSN: 2666-5018


× No keyword cloud information.
We thank Doundoulakis and colleagues for their interest in our study demonstrating that ventricular tachycardia or ventricular fibrillation was the presenting rhythm in ∼50% of the in-hospital cardiac arrests among patients with heart failure with preserved ejection fraction (EF). Determining whether cardiac arrests occur owing to shockable arrhythmias is a key step in the quest to reduce sudden cardiac death (SCD) in heart failure with preserved EF. However, more work needs to be done to prevent SCD, particularly in patients with EF >35% who are not eligible for primary-prevention implantable cardioverter-defibrillator (ICD) therapy based on the current practice guidelines. Thus, it was with much intrigue that we revisited the PRESERVE EF study by Gatzoulis and colleagues. Using a 2-step approach consisting of noninvasive risk factors on surface electrocardiogram followed by programmed ventricular stimulation, they identified post–myocardial infarction (MI) patients with EF ≥40% who had a high risk of SCD. These patients had a high incidence of appropriate ICD discharges during follow-up, supporting this approach. Similarly, we recently published a multivariable risk prediction model for SCD among 31,286 post-MI patients with EF >35%, using widely available clinical characteristics. It is conceivable that the combination of our clinical risk model with the 2-step electrophysiological approach proposed by Gatzoulis and colleagues could further define those at the highest risk of SCD post-MI, who may benefit from ICD therapy.
  5 in total

1.  Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.

Authors:  Selcuk Adabag; Kristen K Patton; Alfred E Buxton; Thomas S Rector; Kristine E Ensrud; Kairav Vakil; Wayne C Levy; Jeanne E Poole
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

2.  Sudden cardiac death risk prediction in heart failure with preserved ejection fraction.

Authors:  Selçuk Adabag; Lisa Langsetmo
Journal:  Heart Rhythm       Date:  2019-12-13       Impact factor: 6.343

3.  Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

Authors:  Konstantinos A Gatzoulis; Dimitrios Tsiachris; Petros Arsenos; Christos-Konstantinos Antoniou; Polychronis Dilaveris; Skevos Sideris; Emmanuel Kanoupakis; Emmanouil Simantirakis; Panagiotis Korantzopoulos; Ioannis Goudevenos; Panagiota Flevari; Efstathios Iliodromitis; Antonios Sideris; Vassilios Vassilikos; Nikolaos Fragakis; Konstantinos Trachanas; Michail Vernardos; Ioannis Konstantinou; Konstantinos Tsimos; Iosif Xenogiannis; Konstantinos Vlachos; Athanasios Saplaouras; Konstantinos Triantafyllou; Ioannis Kallikazaros; Dimitrios Tousoulis
Journal:  Eur Heart J       Date:  2019-09-14       Impact factor: 29.983

4.  Arrhythmic causes of in-hospital cardiac arrest among patients with heart failure with preserved ejection fraction.

Authors:  Matthew Hooks; Michael C Downey; Stephanie Joppa; Albertine Beard; Amy Gravely; Venkat Tholakanahalli; Selçuk Adabag
Journal:  Heart Rhythm O2       Date:  2021-11-02

5.  Predictors of Sudden Cardiac Arrest Among Patients With Post-Myocardial Infarction Ejection Fraction Greater Than 35.

Authors:  Selçuk Adabag; Patrick Zimmerman; Daniel Lexcen; Alan Cheng
Journal:  J Am Heart Assoc       Date:  2021-07-14       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.